G
Guangzhou LBP Medicine Science & Technology Co Ltd
SSE:688393
Guangzhou LBP Medicine Science & Technology Co Ltd
SSE:688393
Price:
22.69
CNY
-3.41%
Market Closed
Market Cap:
¥2.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
G
|
Guangzhou LBP Medicine Science & Technology Co Ltd
SSE:688393
|
CN |
|
Lavvi Empreendimentos Imobiliarios Ltda
BOVESPA:LAVV3
|
BR |
|
Pokarna Ltd
NSE:POKARNA
|
IN |
|
Astra International Tbk PT
OTC:PTAIY
|
ID |
|
MIRC Electronics Ltd
NSE:MIRCELECTR
|
IN |
Cash Flow Statement
Cash Flow Statement
Guangzhou LBP Medicine Science & Technology Co Ltd
Guangzhou LBP Medicine Science & Technology Co Ltd
Currency: CNY
| Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||
| Stock-Based Compensation |
0
|
0
|
0
|
8
|
0
|
0
|
0
|
6
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Taxes Paid |
(43)
|
(28)
|
(27)
|
(23)
|
(25)
|
(28)
|
(25)
|
(27)
|
(27)
|
(27)
|
(29)
|
(31)
|
(29)
|
(26)
|
(26)
|
|
| Change in Working Capital |
(342)
|
(305)
|
(324)
|
(321)
|
(327)
|
(330)
|
(319)
|
(321)
|
(325)
|
(325)
|
(318)
|
(315)
|
(297)
|
(281)
|
(286)
|
|
| Cash from Operating Activities |
60
N/A
|
48
-20%
|
27
-43%
|
10
-64%
|
(8)
N/A
|
(13)
-51%
|
(4)
+72%
|
17
N/A
|
11
-38%
|
16
+54%
|
18
+8%
|
4
-80%
|
32
+801%
|
34
+6%
|
39
+14%
|
|
| Investing Cash Flow | ||||||||||||||||
| Capital Expenditures |
(172)
|
(163)
|
(171)
|
(72)
|
(61)
|
(21)
|
5
|
(38)
|
(38)
|
(43)
|
(26)
|
(24)
|
(12)
|
(13)
|
(16)
|
|
| Other Items |
(184)
|
(137)
|
(184)
|
(43)
|
(147)
|
(141)
|
(19)
|
5
|
32
|
42
|
18
|
81
|
(0)
|
(10)
|
(29)
|
|
| Cash from Investing Activities |
(355)
N/A
|
(300)
+16%
|
(355)
-18%
|
(115)
+68%
|
(208)
-81%
|
(162)
+22%
|
(15)
+91%
|
(33)
-122%
|
(6)
+83%
|
(1)
+79%
|
(8)
-517%
|
57
N/A
|
(12)
N/A
|
(23)
-88%
|
(45)
-99%
|
|
| Financing Cash Flow | ||||||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
0
|
0
|
8
|
0
|
0
|
12
|
4
|
|
| Net Issuance of Debt |
0
|
0
|
15
|
7
|
0
|
(1)
|
(3)
|
7
|
(13)
|
2
|
(5)
|
(14)
|
1
|
7
|
4
|
|
| Cash Paid for Dividends |
0
|
(25)
|
(25)
|
(27)
|
(27)
|
(15)
|
(15)
|
(13)
|
(13)
|
(15)
|
(16)
|
(15)
|
0
|
(9)
|
(8)
|
|
| Other |
(8)
|
11
|
11
|
(2)
|
(5)
|
(6)
|
(6)
|
(3)
|
(2)
|
(3)
|
(14)
|
(6)
|
(6)
|
(14)
|
(4)
|
|
| Cash from Financing Activities |
(27)
N/A
|
(7)
+73%
|
1
N/A
|
(21)
N/A
|
(25)
-15%
|
(19)
+24%
|
(21)
-13%
|
(7)
+67%
|
(27)
-287%
|
(17)
+37%
|
(27)
-61%
|
(35)
-29%
|
(20)
+43%
|
(13)
+37%
|
(12)
+2%
|
|
| Change in Cash | ||||||||||||||||
| Effect of Foreign Exchange Rates |
(0)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
(0)
|
|
| Net Change in Cash |
(323)
N/A
|
(259)
+20%
|
(327)
-26%
|
(126)
+61%
|
(240)
-90%
|
(193)
+20%
|
(39)
+80%
|
(22)
+43%
|
(22)
+3%
|
(1)
+93%
|
(17)
-1 026%
|
26
N/A
|
(0)
N/A
|
(1)
-438%
|
(19)
-1 269%
|
|
| Free Cash Flow | ||||||||||||||||
| Free Cash Flow |
(112)
N/A
|
(115)
-3%
|
(143)
-25%
|
(62)
+56%
|
(69)
-11%
|
(33)
+52%
|
1
N/A
|
(21)
N/A
|
(28)
-33%
|
(27)
+3%
|
(8)
+69%
|
(20)
-141%
|
20
N/A
|
21
+5%
|
22
+6%
|
|
Switch to:
Switch to:
See Also
Discover More
